Clinical trials are an important step in discovering new treatments for lupus and other diseases, as well as new ways to detect, diagnose, and reduce the risk of disease. In clinical trials, people volunteer to test new treatments, interventions or tests, thereby showing researchers what does and doesn’t work in people. Clinical trials also help researchers and doctors decide if the side effects of a new treatment are acceptable when weighed against the benefits.
As in all fields of scientific inquiry, lupus research has been greatly advanced by the caring people who participate in clinical trials. In these studies – usually sponsored by a government organization, a pharmaceutical company or a biotech firm – scientists and participants work together to find safer, more effective methods to diagnose, prevent, treat, and ultimately cure lupus.
Our objective is to get as many qualified people enrolled in lupus clinical trials as possible, to help accelerate the development-to-treatment process. Medicines can affect people differently and must be tested among each potential patient group— by race, gender, age, and ethnic background— so doctors can know how to use them safely and effectively. This is especially important for those that are disproportionately affected by lupus.
For more information about all the lupus clinical trials in the country and the possibility of participating in one, please visit lupustrials.org.
There are many types of clinical trials to join. Visit LupusTrials.org to learn more and talk to your doctor about what trials may be right for you.
